Drugs / MG-CLR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06602284 | Oct 2024 → Mar 2025 overdue | acne | Equipmed USA LLC | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MG-CLR | “Dermapen 4™ conjunction with MG-CLR” NCT06602284 ↗ |